abstract |
Describes a method of treating both conditions prophylactically and therapeutically in relation to A [beta] peptide activity. The method uses a humanized antibody fragment that specifically binds between amino acid positions 13-28 of human A [beta] peptide, wherein the antibody fragment is covalently linked to a polyethylene glycol (PEG) molecule. |